Lastly, protein expression of the ANXA6 gene (mutated only in two patients with a CR) is required for membrane localization of activated EGFR and persistent activation of MAP kinaseERK1/2 and PI3K/Akt pathways in invasive breast cancer cells. The gene discussed is EGFR; the disease is invasive breast carcinoma.